Orlistat Treatment of Crigler-Najjar Disease

计划入组 16 人 · 首次发布于 2007 年 4 月 18 日

Clinical Assessment Study in Crigler-Najjar Syndrome

计划入组 8 人 · 首次发布于 2017 年 3 月 14 日

Gene Therapy for Severe Crigler Najjar Syndrome

计划入组 17 人 · 首次发布于 2018 年 3 月 15 日

Naja naja（atra）Antivenin (Shanghai Serum Bio)

Naja Antivenin(Shanghai Serum Biotechnology)

Thomas Riegler

Germany

Gerhard Rogler

Switzerland

NAJRAN UNIVERSITY

Saudi Arabia

Imlifidase Shows Promise in Guillain-Barré Syndrome and Expands Gene Therapy Access

Hansa Biopharma's Imlifidase Shows Promise in Guillain-Barré Syndrome and Anti-GBM Disease

Genethon's GNT0004 Gene Therapy Shows Promise in Duchenne Muscular Dystrophy Trial